This was announced by Hanspeter Spek, CEO of Sanofi Group, during his working visit to Vietnam.

Currently, Sanofi Group has two pharmaceutical factories in Ho Chi Minh City with 80 percent of total production output consumed in Vietnam and 20 percent exported to Asian countries. 

Sanofi-Synthelabo Viet Nam Pharmaceutical Venture Company’s turnover in 2011 increased by 24 percent over 2010, and its exports reached US$6 million.

In the first quarter of 2012, Sanofi Vietnam achieved a growth rate of 22 percent, ranking the second among multi-national companies operating in Vietnam.

The global group, which gained a turnover of EUR34 billion last year, also plans to expand operations in Laos and Cambodia.